These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1755847)

  • 1. Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor.
    Seiler SM; Goldenberg HJ; Michel IM; Hunt JT; Zavoico GB
    Biochem Biophys Res Commun; 1991 Dec; 181(2):636-43. PubMed ID: 1755847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase.
    Seiler SM; Michel IM; Fenton JW
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1296-302. PubMed ID: 1371679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist.
    Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S
    Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
    Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
    Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cleaved peptide of the thrombin receptor is a strong platelet agonist.
    Furman MI; Liu L; Benoit SE; Becker RC; Barnard MR; Michelson AD
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3082-7. PubMed ID: 9501219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist receptors and G proteins as mediators of platelet activation.
    Brass LF; Hoxie JA; Kieber-Emmons T; Manning DR; Poncz M; Woolkalis M
    Adv Exp Med Biol; 1993; 344():17-36. PubMed ID: 8209785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations.
    Tesfamariam B; Allen GT; Normandin D; Antonaccio MJ
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1744-9. PubMed ID: 8238588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.
    Chao BH; Kalkunte S; Maraganore JM; Stone SR
    Biochemistry; 1992 Jul; 31(27):6175-8. PubMed ID: 1320929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation.
    Hasan AA; Amenta S; Schmaier AH
    Circulation; 1996 Aug; 94(3):517-28. PubMed ID: 8759097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide.
    Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA
    Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thrombin receptor activating peptide on phosphoinositide hydrolysis and protein kinase C activation in cultured rat aortic smooth muscle cells: evidence for "tethered-ligand" activation of smooth muscle cell thrombin receptors.
    Webb ML; Taylor DS; Molloy CJ
    Biochem Pharmacol; 1993 Apr; 45(8):1577-82. PubMed ID: 8387299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide analogue of thrombin receptor-activating peptide inhibits thrombin and thrombin-receptor-activating peptide-induced vascular smooth muscle cell proliferation.
    Pakala R; Liang CT; Benedict CR
    J Cardiovasc Pharmacol; 2001 May; 37(5):619-29. PubMed ID: 11336112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells.
    Ngaiza JR; Jaffe EA
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1656-61. PubMed ID: 1656962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.